Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer-Reference-Cited by-同舟云学术

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

Published:2014-05 Issue:5 Volume:16 Page:430-438
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Tzeng Ching-Wei D.,Balachandran Aparna,Ahmad Mediha,Lee Jeffrey E.,Krishnan Sunil,Wang Huamin,Crane Christopher H.,Wolff Robert A.,Varadhachary Gauri R.,Pisters Peter W.T.,Aloia Thomas A.,Vauthey Jean-Nicolas,Fleming Jason B.,Katz Matthew H.G.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence-based appraisal;Ballehaninna;J Gastrointest Oncol,2012

2. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation;Katz;Ann Surg Oncol,2010

3. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma;Maithel;Ann Surg Oncol,2008

4. Selective use of staging laparoscopy based on carbohydrate antigen 19-9 level and tumour size in patients with radiographically defined potentially or borderline resectable pancreatic cancer;Satoi;Pancreas,2011

5. Serum CA 19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma;Sugiura;J Gastrointest Surg,2012

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Significance of Collagen VI in Pancreatic Ductal Adenocarcinoma;Pancreas;2024-06-24

2. Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study;Pancreatology;2024-06

3. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17

4. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study;British Journal of Surgery;2024-03

5. Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS;Cancers;2024-02-23